Hemorrhagic disease of the newborn

Also known as: Haemorrhagic disease of newborn / Hemorrhagic disease of the newborn due to vitamin K deficiency (disorder) / Hemorrhagic disease of newborn / Vitamin K deficiency of newborn

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB01022	Phylloquinone	A fat soluble vitamin used to treat hemorrhagic conditions in infants and coumarin overdoses.

Drug	Drug Name	Target	Type
DB01022	Phylloquinone	Vitamin K-dependent gamma-carboxylase	target
DB01022	Phylloquinone	Osteocalcin	target
DB01022	Phylloquinone	Leukotriene-B(4) omega-hydroxylase 1	enzyme
DB01022	Phylloquinone	UbiA prenyltransferase domain-containing protein 1	enzyme
DB01022	Phylloquinone	Vitamin K epoxide reductase complex subunit 1	enzyme

Drug	Drug Name	Phase	Status	Count